Basiliximab Prophylaxis

Basiliximab Prophylaxis is a monoclonal antibody-based immunosuppressive regimen that selectively targets the interleukin-2 receptor on activated T cells to prevent acute organ rejection in the early post-transplantation period.

13

Publications

403

Citations

80

Authors

24

Institutions

Publications per year

2017–2026

2

Authors

80

  1. QW
    Qiuling Wu

    Huazhong University of Science and Technology, China

    2 publications · 51 citations

    2

    h-index

  2. JF
    Jun Fang

    Huazhong University of Science and Technology, China

    2 publications · 51 citations

    2

    h-index

  3. BN
    Björn Nashan

    Medizinische Hochschule Hannover, Germany

    1 publications · 17 citations

    1

    h-index

  4. BG
    Benjamín Gómez-Navarro

    Mexican Social Security Institute, Mexico

    1 publications · 11 citations

    1

    h-index

  5. CX
    C-Q Xun

    University of Kentucky, United States

    1 publications · 52 citations

    1

    h-index

1–5 of 80

Venues

  1. Transplantation Proceedings

    4 publications · 44 citations

    4

    h-index

  2. Bone Marrow Transplantation

    2 publications · 81 citations

    2

    h-index

  3. The Journal of Heart and Lung Transplantation

    2 publications · 100 citations

    2

    h-index

  4. Transplant International

    1 publications · 17 citations

    1

    h-index

  5. Biology of Blood and Marrow Transplantation

    TCT · 1 publications · 22 citations

    1

    h-index

1–5